Prednisolone: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "2 mg" to "2mg") |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
Line 16: | Line 16: | ||
===[[Adrenal insufficiency]]=== | ===[[Adrenal insufficiency]]=== | ||
*4- | *4-5mg/m^2 PO qd | ||
===[[Multiple sclerosis]], acute exacerbation=== | ===[[Multiple sclerosis]], acute exacerbation=== | ||
Line 39: | Line 39: | ||
===[[Adrenal insufficiency]]=== | ===[[Adrenal insufficiency]]=== | ||
*4- | *4-5mg/m^2 PO qd | ||
===[[Nephrotic syndrome]]=== | ===[[Nephrotic syndrome]]=== |
Revision as of 03:19, 21 July 2016
General
- Type: Corticosteroid
- Dosage Forms: 5; 5,15,25/5 mL
- Common Trade Names: Flo-Pred, Millipred, Oraped, Pedipred, Prelone, Veripred 20
Adult Dosing
Corticosteroid-responsive conditions
- 5-60mg/day PO divided qd-qid
Asthma, acute
- ED/hospital: 40-80mg/day PO divided qd-bid, cont. until peak flow = 70% predicted
- Outpatient burst treatment: 40-60mg/day PO divided qd-bid x 3-10 days
Asthma, severe persistent
- 7.5-60mg PO qd-qod
Adrenal insufficiency
- 4-5mg/m^2 PO qd
Multiple sclerosis, acute exacerbation
- 200mg PO qd x 1 wk, then 80mg PO qod x 1 mo
Alcoholic hepatitis, acute
- 40mg PO qd
Pediatric Dosing
Corticosteroid-responsive conditions
- 0.14-2mg/kg/day PO divided qd-qid
Asthma, acute
- ED/hospital: 1-2mg/kg/day PO divided qd-bid
- Max: 60mg/day, cont. until peak flow = 70% predicted
- Outpatient burst treatment: 1-2mg/kg/day PO divided qd-bid x 3-10 days
- Max: 60mg/day
Asthma, severe persistent
- 0.25-2mg/kg PO qd-qod
- Max 60mg/day
Adrenal insufficiency
- 4-5mg/m^2 PO qd
Nephrotic syndrome
- 60mg/m^2/day PO divided tid x 4 wk, then 40mg/m^2 PO qod x 4 wk
Special Populations
- Pregnancy Rating: C
- Lactation: Probably Safe
- Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
- systemic fungal infection
- active or recent varicella infection
- active or recent measles infection
- avoid abrupt withdrawal (high dose or long-term use)
- caution if active infection
- caution if TB infection
- caution if ocular HSV
- caution if immunosuppressed
- caution if HTN
- caution if CHF
- caution if diabetes mellitus
- caution if seizure disorder
- caution if PUD
- caution if ulcerative colitis
- caution if diverticulitis
- caution if recent intestinal anastomosis
- caution if psychiatric disorder
- caution if hypothyroidism
- caution if osteoporosis
- caution if myasthenia gravis
- caution if renal impairment, severe
- caution if hepatic impairment, severe
- caution if thromboembolic disorder
- caution if coagulation disorder
- caution in elderly patients
Adverse Reactions
Serious
- adrenal insufficiency
- Cushing syndrome
- immunosuppression
- infection
- HTN
- CHF
- diabetes mellitus
- steroid psychosis
- GI perforation/ulcer
- osteopenia/osteoporosis
- hypokalemic alkalosis
- steroid myopathy
- tendon rupture
- pseudotumor cerebri
- ICP increase
- seizures
- glaucoma
- cataracts
- pancreatitis
- growth suppression (long-term use, peds patients)
- exophthalmos
- anaphylaxis
- withdrawal symptoms if abrupt discontinuation (high dose or long-term use)
Common
- sodium and fluid retention
- diaphoresis
- headache
- vertigo
- insomnia
- nervousness
- mood swings
- edema
- muscle weakness
- BP elevation
- glucose intolerance
- petechiae/ecchymosis
- facial erythema
- menstrual irregularities
- hypokalemia
- IOP increase
- impaired wound healing (long-term use)
- Cushing syndrome
- skin pigmentation abnormality
- hirsutism
- urticaria
Pharmacology
- Half-life: 18-36h
- Metabolism: liver, CYP450: 3A4 substrate
- Excretion: urine
- Mechanism of Action: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects